Literature DB >> 35908134

Tear film instability is associated with weakened colocalization between occludin and MUC5AC in scopolamine-induced dry eye disease (DED) rats.

Kun Xu1,2, Xian-Ning Liu3, Hong-Bing Zhang3, Xiu-Ping Zhu3, Xian-Jiao Zhang3.   

Abstract

PURPOSE: Dry eye disease (DED) is a disease with tear film instability because of multiple factors. This study was conducted to explore roles of occludin and MUC5AC in tear film instability in DED rat model.
METHODS: A total of 20 SD rats were divided into DED group (n = 10) and normal control (NC) group (n = 10). DED rat model was established by subcutaneously injecting with scopolamine hydrobromide. Clinical examinations, including tear breakup time (tBUT), Schirmer's test and corneal fluorescein staining, were conducted to determine corneal functions. Transmission electron microscopy was used to measure the ultrastructures of corneal epithelial cells. Western blotting assay was used to identify occludin expression in corneal tissues of DED rats. Real-time PCR (RT-PCR) was performed to verify gene transcription of occludin and MUC5AC. Colocalization between occludin and MUC5AC was identified with confocal fluorescence microscopy.
RESULTS: Tear breakup time was significantly shorter, and corneal fluorescein staining score was predominantly higher in DED rats compared to those in normal rats (P < 0.05). Normal rats showed a steady tear secretion throughout the whole experiments, while DED rats showed a dramatic reduction on day 14. DED rats demonstrated ultrastructural damage of Golgi apparatus and endoplasmic reticulum in corneal epithelial cells. Occludin and MUC5AC expressions were significantly downregulated in corneal tissue of DED rats compared with those of normal rats (P < 0.05). Percentage of occludin-MUC5AC-colocalized corneal epithelial cells in DED rats was significantly less compared with those in normal rats (P < 0.01).
CONCLUSIONS: Tear film stability was damaged in scopolamine-induced DED rats because of the weakened colocalization between occludin and MUC5AC molecule. This study would provide a potential clue for the pathogenesis and a promising theoretical basis for clinical work of DED.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Corneal epithelial cells; Dry eye disease (DED); MUC5AC,; Occludin; Tear film

Year:  2022        PMID: 35908134     DOI: 10.1007/s10792-022-02443-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  6 in total

Review 1.  The pathophysiology, diagnosis, and treatment of dry eye disease.

Authors:  Elisabeth M Messmer
Journal:  Dtsch Arztebl Int       Date:  2015-01-30       Impact factor: 5.594

2.  Tight Junction Protein Occludin Is a Porcine Epidemic Diarrhea Virus Entry Factor.

Authors:  Xiaolei Luo; Longjun Guo; Jian Zhang; Yunfei Xu; Weihong Gu; Li Feng; Yue Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  The phenol red thread tear test: a cross-cultural study.

Authors:  R Sakamoto; E S Bennett; V A Henry; S Paragina; T Narumi; Y Izumi; Y Kamei; E Nagatomi; Y Miyanaga; H Hamano
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-12       Impact factor: 4.799

4.  [The protection of hydrogen-rich saline on a rat dry eye model induced by scopolamine hydrobromide].

Authors:  Y Y Chu; N Hua; Y S Ru; S Z Zhao
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2017-05-11

5.  [Effects of respiratory syncytial virus infection on epidermal growth factor receptor, tight junction association proteins and mucin in airway epithelial cells].

Authors:  Juan-Juan Liu; Ting Zhang; Yu-Mei Mi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-03

6.  The tear fluid mucin 5AC change of primary angle-closure glaucoma patients after short-term medications and phacotrabeculectomy.

Authors:  Wei Liu; Huilin Li; Duanyang Lu; Juan Liang; Xiaoli Xing; Aihua Liu; Shaozhen Zhao; Xiaorong Li; Jian Ji
Journal:  Mol Vis       Date:  2010-11-09       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.